EMA - Consultation on Draft Guideline on core SmPC for human normal immunoglobulin for subcutaneous and intramuscular administration (SCIg/IMIg)
The draft of the new version of the Guideline on core SmPC for human normal immunoglobulin for subcutaneous and intramuscular administration (SCIg/IMIg) has been published for consultation. Interested contributors have until 31 May to comment. The purpose of this core SmPC is to provide applicants and regulators with harmonised guidance on the information to be included in the Summary of product characteristics (SmPC) for a human normal immunoglobulin for subcutaneous and/or intramuscular ad...
Publication Details
- Journal
- Industrias Culturais (Universidade de Coimbra)
- Published
- 2025-02-05
- DOI
- https://doi.org/10.58079/13919
- Primary Topic
- History of Computing Technologies
- Type
- article
- Field-Weighted Citation Impact
- 0.00